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Background: Patient-initiated services in rheumatology have been found to be cost-saving 
without compromising the clinical or psychosocial well-being of patients with rheumatoid 
arthritis. Self-monitoring is a technique used in many other long-term conditions and is 
associated with reductions in healthcare utilisation and mortality and has been found to be 
satisfactory from the patient’s perspective. The aim of this RCT was to evaluate the efficacy 
of a service which integrates self-monitoring into patient-initiated follow-ups for patients 
with RA or PsA on methotrexate; in terms of healthcare utilisation and clinical outcomes.  
Methods: A RCT was conducted at UCLH in which 100 patients with RA or PsA on 
methotrexate were randomised to either an intervention group or usual care. All 
participants were in the trial for 6 blood tests. Those in the intervention group attended a 
one-off training session where they were taught how to monitor their blood test results and 
which symptoms and side effects to report. These participants had no scheduled 
appointments with their rheumatology nurse during the trial period, but continued to see 
their consultant appointments as usual. Blood test results were sent to intervention 
participants and along with their symptoms and side effects patients were required to 
initiate a review with their nurse, when necessary. Patients were booked an emergency 
outpatients appointment if required. Healthcare utilisation was monitored throughout the 
trial period. The Mann-Whitney U test and multi-level modelling were used to explore the 
impact of the intervention on healthcare usage and clinical outcomes.  
Results: Across the trial period 78.85% of decisions made by intervention participants were 
correct. There were no significant differences in clinical or demographic variables between 
the two groups at baseline. At the end of the trial period participants in the intervention 
group had 54.55% fewer appointments with their rheumatology nurse specialist (p<0.0001). 
There were no significant differences in the number of appointments with the 
rheumatologist or GP, although participants in the intervention group did have 38.80% 
fewer GP appointments than controls. Levels of pain, fatigue, ESR, CRP and treatment 
response (as measured by the EULAR treatment response criteria for RA and PsARC) did not 
differ between groups (p>0.05). 
Conclusions: Patients with RA and PsA can successfully understand and interpret their blood 
test results and use this information along with reports of their symptoms and side effects 
to initiate reviews with their rheumatology nurse. Participants in the intervention group had 
fewer hospital reviews with their nurse specialist with no detrimental effects to their clinical 
status and with no increase in visits to the rheumatologist or GP. This model of care may 
therefore be a viable alternative for established RA and PsA patients on DMARD therapy. 
 
References 
 (1)  Hewlett S, Mitchell K, Haynes J, Paine T, Korendowych E, Kirwan JR. Patient-initiated 
hospital follow-up for rheumatoid arthritis. Rheumatology 2000; 39(9):2000. 
 (2)  Hewlett S, Kirwan J, Pollock J, Mitchell K, Hehir M, Blair PS et al. Patient initiated 
outpatient follow up in rheumatoid arthritis: six year randomised controlled trial. BMJ 
2005; 330(7484):171. 
 (3)  Kirwan JR, Mitchell K, Hewlett S, Hehir M, Pollock J, Memel D et al. Clinical and 
psychological outcome from a randomized controlled trial of patient-initiated direct-
access hospital follow-up for rheumatoid arthritis extended to 4 years. Rheumatology 
2003; 42(3):422-426. 
 (4)  Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. A Meta-Analysis of Remote 
Monitoring of Heart Failure Patients. Journal of the American College of Cardiology 
2009; 54(18):1683-1694. 
 (5)  Jaana M, Pare G, Sicotte C. Hypertension home telemonitoring: current evidence and 
recommendations for future studies. Disease Management & Health Outcomes 2007; 
15(1):19-31. 
 (6)  Clark RA, Inglis SC, McAlister FA, Cleland JGF, Stewart S. Telemonitoring or structured 
telephone support programmes for patients with chronic heart failure: systematic 
review and meta-analysis. BMJ 2007; 334(7600):942-950. 
 
 
 
